ADDRESSING THE COMPLIANCE GAP WHAT · ADDRESSING THE COMPLIANCE GAP Only one third of the eligible...
1
Webinars and workshops to improve the lowest performing metrics WHO’S INVOLVED? EXPANDING THE USE OF GUIDELINES & IMPROVING CV HEALTH THROUGH: Data collection Process improvement Feedback Analysis WHAT IS CCC? Improving Care for Cardiovascular Disease in China (CCC) is a multi-year project focussed on improving compliance with evidence-based therapy for patients with ACS and AFib in almost 200 tertiary and secondary hospitals across China. WHAT’S NEXT? Enhance communication between National Health Commission (NHC) on a national and local level by sharing project results Strengthen transitions from hospital to home, improving patient adherence to medications and reducing the risk of secondary events ADDRESSING THE COMPLIANCE GAP Only one third of the eligible NSTE-ACS patients received timely PCI according to the guidelines 1 Only 57.4% of patients with STEMI received acute reperfusion therapy 1 WHAT’S THE PROGRAMME ACHIEVED SO FAR? Groundbreaking number of records in the system: 103,298 for ACS and 54,863 for AFib Groundbreaking number of publications: 8 for ACS and 1 for AFib 76% compliance rate in guideline-led care for ACS patients among those hospitals enrolled 76% CCC is supported by funding from Chinese Society of Cardiology American Heart Association Reference | 1. Hao Y et al. Sex Differences in In-Hospital Management and Outcomes of Patients With Acute Coronary Syndrome: Findings from the CCC Project. Circulation.2019;139(15):1776-1785. Document ID: Z4-17998 | Date of Preparation: August 2019 | Date of Expiry: August 2021. Replicate nationwide, to potentially improve outcomes for millions more patients
Transcript of ADDRESSING THE COMPLIANCE GAP WHAT · ADDRESSING THE COMPLIANCE GAP Only one third of the eligible...
Webinars and workshops to improve the lowest performing metrics
WHO’S INVOLVED? EXPANDING THE USE OF GUIDELINES & IMPROVING CV HEALTH THROUGH:
Data collection
Process improvement
FeedbackAnalysis
WHAT IS CCC?Improving Care for Cardiovascular Disease in China (CCC) is a multi-year project focussed on improving compliance with evidence-based therapy for patients with ACS and AFib in almost 200 tertiary and secondary hospitals across China.
WHAT’S NEXT?
Enhance communicationbetween National Health Commission (NHC) on a national and local level by sharing project results
Strengthen transitions from hospital to home, improving patient adherence to medications and reducing the risk of secondary events
ADDRESSING THE COMPLIANCE GAP
Only one third of the eligible NSTE-ACS patients received timely PCI according to the guidelines1
Only 57.4% of patients with STEMI received acute reperfusion therapy1
WHAT’S THE PROGRAMME ACHIEVED SO FAR?
Groundbreaking number of records in the system: 103,298 for ACS and 54,863 for AFib
Groundbreaking number of publications:8 for ACS and 1 for AFib
76% compliance rate in guideline-led care for ACS patients among those hospitals enrolled
76%
CCC is supported by funding from
Chinese Society of CardiologyAmerican Heart Association
Reference | 1. Hao Y et al. Sex Differences in In-Hospital Management and Outcomes of Patients With Acute Coronary Syndrome: Findings from the CCC Project. Circulation.2019;139(15):1776-1785.Document ID: Z4-17998 | Date of Preparation: August 2019 | Date of Expiry: August 2021.
Replicate nationwide, to potentially improveoutcomes for millionsmore patients
